Correlation Between ACR TI-RADS and Bethesda System in Thyroid Nodules ACR TI-RADS ve Bethesda Sistemi Arasındaki Korelasyon: Tiroid Nodülleri Üzerine Bir Çalışma


Buyukceran E. U., Atasoy G., Kula S., Dilek I., ARIK E., Kaya F., ...Daha Fazla

Genel Tip Dergisi, cilt.35, sa.5, ss.805-813, 2025 (Scopus, TRDizin) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 35 Sayı: 5
  • Basım Tarihi: 2025
  • Doi Numarası: 10.54005/geneltip.1594269
  • Dergi Adı: Genel Tip Dergisi
  • Derginin Tarandığı İndeksler: Scopus, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.805-813
  • Anahtar Kelimeler: ACR TI-RADS, bethesda system, fine-needle aspiration, Thyroid nodules
  • Ankara Üniversitesi Adresli: Evet

Özet

Aim: Thyroid nodules are frequently encountered in clinical practice Fine-needle aspiration (FNA) cytology is a reliable method to assess malignancy potential, though most nodules are benign. The American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) standardizes ultrasound evaluation, aiding malignancy risk stratification and reducing unnecessary biopsies. Methods: This retrospective study analyzed 182 patients who underwent thyroid ultrasound and FNA between August 2023 and August 2024. Nodules were classified using the ACR TI-RADS and Bethesda systems. Chi-square and receiver operating characteristic (ROC) curve analyses assessed correlations between classifications. Results: The mean age was 49.77 years, with 159 females (87.36%) and 23 males (12.64%). Most nodules were categorized as ACR TI-RADS 3 (n = 120, 65.93%) and Bethesda 2 (n = 148, 81.32%), indicating benignity. Higher ACR TI-RADS scores correlated with increased malignancy risk, with ACR TI-RADS 5 nodules (n = 5, 2.75%) aligning with Bethesda 5 (n = 5, 2.75%). ROC analysis showed an area under the curve (AUC) of 0.93 for malignancy detection, demonstrating strong discriminatory power. Conclusions: ACR TI-RADS aligns well with Bethesda results, effectively stratifying thyroid nodule risk and reducing unnecessary interventions.